e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Exacerbations of asthma and COPD: assessment, impact and novel treatments
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased risk of mortality in COPD patients using tiotropium respimat vs. tiotropium Handihaler
K. Verhamme, A. Afonso, S. Romio, B. Stricker, G. Brusselle, M. Sturkenboom (Rotterdam, Netherlands; Ghent, Belgium)
Source:
Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments
Session:
Exacerbations of asthma and COPD: assessment, impact and novel treatments
Session type:
Oral Presentation
Number:
196
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Verhamme, A. Afonso, S. Romio, B. Stricker, G. Brusselle, M. Sturkenboom (Rotterdam, Netherlands; Ghent, Belgium). Increased risk of mortality in COPD patients using tiotropium respimat vs. tiotropium Handihaler. Eur Respir J 2012; 40: Suppl. 56, 196
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Use of tiotropium Respimat versus HandiHaler and mortality in patients with COPD
Source: Eur Respir J 2014; 43: 1818-1819
Year: 2014
Use of tiotropium Respimat versus HandiHaler and mortality in patients with COPD
Source: Eur Respir J 2014; 43: 1816-1818
Year: 2014
Comparison of spirometric efficacy of fluticasone/salmeterol plus tiotropium and tiotropium alone in moderate COPD
Source: Annual Congress 2009 - New bronchodilators
Year: 2009
Improvement in dyspnea with fluticasone/salmeterol compared with salmeterol or ipratropium in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 88s
Year: 2004
AMPLIFY: efficacy of aclidinium vs tiotropium in COPD
Source: International Congress 2018 – COPD management
Year: 2018
Benefit of budesonide/formoterol compared with salmeterol/fluticasone in COPD patients in the morning
Source: Annual Congress 2009 - Healthcare and treatment of COPD
Year: 2009
Efficacy of tiotropium and olodaterol fixed-dose combination in patients with COPD on β-blockers
Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD
Year: 2015
Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe COPD in France
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017
Formoterol given either alone or together with tiotropium, reduces the rate of exacerbations in stable COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 430s
Year: 2006
LATE-BREAKING ABSTRACT: Benefits of dual bronchodilation with QVA149 once daily versus placebo, indacaterol, NVA237 and tiotropium in patients with COPD: The SHINE study
Source: Annual Congress 2012 - New drug targets and pre-clinical models for respiratory diseases
Year: 2012
Comparison of the pharmacokinetics and pharmacodynamics of once daily tiotropium Respimat® and tiotropium HandiHaler® in COPD patients
Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD
Year: 2013
Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study
Source: Eur Respir J 2012; 40: 1106-1114
Year: 2012
NVA237 once daily reduces the percentage of patients with exacerbations of COPD and associated hospitalizations: The GLOW1 trial
Source: Annual Congress 2011 - New treatments for airway disease
Year: 2011
Clinical efficacy and patients‘ satisfaction for 100 consequent COPD patients using tiotropium respimat
Source: Annual Congress 2011 - Bronchodilators in asthma and COPD
Year: 2011
Bronchodilator efficacy of tiotropium in patients with mild COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 616s
Year: 2006
Dose-finding study for tiotropium and olodaterol when administered in combination via the Respimat® inhaler in patients with COPD
Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights
Year: 2012
Efficacy and safety of twice-daily aclidinium bromide compared with tiotropium and placebo in patients with moderate to severe COPD
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010
Safety of tiotropium and olodaterol fixed-dose combination for COPD in patients on β-blockers
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Effectiveness of indacaterol and tiotropium in patients with severe dyspnoea
Source: Annual Congress 2012 - COPD treatments: efficacy and safety
Year: 2012
Comparison of a combination of tiotropium and formoterol to salmeterol and fluticasone in moderate COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 14s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept